Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22370325

FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Jun 1
First author
Bergh J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Jun 1;30(16):1897-900. doi: 10.1200/JCO.2012.41.7394.
    note
    Source null
    related pmid
    22547606
    relationship
    Comment in

Authors and identifiers

  1. name
    Bergh J
    type
    Author
  2. name
    Jönsson PE
    type
    Author
  3. name
    Lidbrink EK
    type
    Author
  4. name
    Trudeau M
    type
    Author
  5. name
    Eiermann W
    type
    Author
  6. name
    Brattström D
    type
    Author
  7. name
    Lindemann JP
    type
    Author
  8. name
    Wiklund F
    type
    Author
  9. name
    Henriksson R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bergh J
    type
    Author
  2. name
    Jönsson PE
    type
    Author
  3. name
    Lidbrink EK
    type
    Author
  4. name
    Trudeau M
    type
    Author
  5. name
    Eiermann W
    type
    Author
  6. name
    Brattström D
    type
    Author
  7. name
    Lindemann JP
    type
    Author
  8. name
    Wiklund F
    type
    Author
  9. name
    Henriksson R
    type
    Author
bibliography ids
  1. nci-bib-47580e18b84e98795044ab98
book metadata
content sha256
285c43f048ba1f7697cd27d7921b6b7b075d6d7c153cf4fb0631943d66fcd7ae
document type
citation
dois
  1. 10.1200/JCO.2011.38.1095
electronic publication date
display
2012 Feb 27
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22370325
immutable id
pubmed:22370325@285c43f048ba1f7697cd27d7921b6b7b075d6d7c153cf4fb0631943d66fcd7ae
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1919-25
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Jun 1;30(16):1897-900. doi: 10.1200/JCO.2012.41.7394.
    note
    Source null
    related pmid
    22547606
    relationship
    Comment in
outcomes validated
false
pmid
22370325
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
639410c4183912d92ea895984d448762f90cc21b5ab88afdbba510839aa52487
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Jun 1
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22370325/
title
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.

Preserved source evidence · Not medical advice